Chirurgische Therapie der primär sklerosierenden Cholangitis

Volume: 92, Issue: 2, Pages: 148 - 157
Published: Jun 2, 2020
Abstract
In recent years substantial progress has been made in the treatment, surveillance and understanding of the pathogenesis of primary sclerosing cholangitis (PSC); however, in most cases liver transplantation (LTX) is still the only curative option for cancer or end-stage liver disease (ELD). In rare cases a partial liver resection is a possible curative treatment of a PSC-associated cholangiocellular carcinoma (CCC). These operations represent a...
Paper Details
Title
Chirurgische Therapie der primär sklerosierenden Cholangitis
Published Date
Jun 2, 2020
Volume
92
Issue
2
Pages
148 - 157
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.